Equillium Inc (EQ)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Equillium Inc (EQ) is up 100.7% since the beginning of the year. At $3 per share, EQ is trading 9.9% below its 52-week high of $3. Investors who bought $1,000 worth of EQ shares 5 years ago would now be looking at an investment worth $449.

Equillium Inc (EQ) has returned 100.65% so far this year and 771.15% over the past 12 months.

Based on dividend-adjusted daily data since Oct 12, 2018, EQ's average daily return is +0.44%, while the average monthly return is +5.16%. At this rate, an investment would double in approximately 1.1 years.

Historically, 46% of months were positive and 54% were negative. The best month was Aug 2025 with a return of +345.0%, while the worst month was Jun 2024 at -53.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, EQ closed higher 46% of trading days. The best single day was Jul 13, 2020 with a return of +730.7%, while the worst single day was Jul 14, 2020 at -47.3%.

Equillium Inc has an annualized alpha of 183.13%, beta of 0.48, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 15, 2018.

• This stock participated in 140.42% of S&P 500 Index downside but only 24.66% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.48 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

EQ ranks 97 for risk / return — in the top 97% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Equillium Inc (EQ) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Equillium Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Equillium Inc was 98.91%, occurring on Jun 23, 2025. The portfolio has not yet recovered.

The current Equillium Inc drawdown is 88.26%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Equillium Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Equillium Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.